Artemisia annua for small intestinal bacterial overgrowth (SIBO)
Part of Digestive system clinical trials.
This trial tests whether a supplement made from Artemisia annua (sweet wormwood) can help people with SIBO, a gut condition. You will take the supplement or a placebo for 5 weeks and have breath tests and blood draws to see how it affects your symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a severe enough IBS (irritable bowel syndrome) score, as determined by a questionnaire
- You must have hydrogen-positive SIBO (small intestinal bacterial overgrowth), confirmed by a breath test
- You must be willing to take the study supplement or placebo daily for 5 weeks
- You must be willing to do two breath tests, follow a special diet the day before each test, and fast overnight before the test
- You must be willing to have three blood draws, each after fasting overnight
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a herbal supplement called Biocidin REMOVE can help people with irritable bowel syndrome (IBS) who also have a condition called small intestinal bacterial overgrowth (SIBO), where too many bacteria grow in the small intestine. The study aims to see if the supplement can reduce symptoms and improve quality of life.
This trial compares two treatments for SIBO, a condition that causes bloating and diarrhea due to too much bacteria in the small intestine. One treatment is a probiotic (a beneficial yeast) and the other is an antibiotic. The goal is to see which one works better.
This study tests whether adding a probiotic supplement to the antibiotic rifaximin improves treatment for people with irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO), a condition where too many bacteria grow in the small intestine. If you have IBS and SIBO, this combination might help reduce your symptoms.
This study uses a tiny capsule to collect samples from your small intestine to learn about gut bacteria in people with IBS or other functional gut disorders. It could help researchers understand what causes digestive symptoms.
This study tests whether the antibiotic rifaximin can relieve bloating in people with small intestinal bacterial overgrowth (SIBO). If you have chronic bloating and a positive SIBO breath test, this trial may be a good fit.
This study tests how Rifaximin (a medicine for SIBO) affects the bacteria and other substances in your gut. You'll swallow a small capsule that collects samples as it travels through your digestive system, so researchers can see how your gut changes during treatment.
Hear when a new Small Intestinal Bacterial Overgrowth Syndrome (SIBO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.